OTC labeling rule
This article was originally published in The Tan Sheet
Executive Summary
CHPA sends questions on OTC labeling rule to FDA Office of OTC Drugs Deputy Director Linda Katz, MD, in an April 13 letter in preparation for the April 23 "feedback" meeting. Among other questions, the group inquires about breaking the Information Panel into two columns, labeling of narrow cartons and using contrasting color to meet the "box" requirement of the rule. CHPA requests the meeting include an FDA briefing on the rule. CHPA Senior VP and Director of Science & Technology William Soller, PhD, is slated to make a presentation on behalf of the association, and Thomas Donegan, VP and General Counsel for CTFA, also may speak. The meeting will take place at 9201 Corporate Blvd., Rockville, Md., from 1:30 to 3:30 p.m